Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | POLB | P06746 | 3/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4056985 | 0.95 | ALDH1A1 (0.42) | ALDH1A1POLBUSP2LMNAKDM4E | |
| SCHEMBL6673706 | 0.86 | POLB (0.46) | ALDH1A1POLBUSP2LMNAKDM4E | |
| SCHEMBL10412697 | 0.85 | KDM4E (0.47) | ALDH1A1POLBUSP2LMNAKDM4E | |
| SCHEMBL28392032 | 0.83 | KDM4E (0.48) | ALDH1A1POLBUSP2LMNAKDM4E | |
| SCHEMBL16904245 | 0.81 | ALDH1A1 (0.40) | ALDH1A1POLBUSP2LMNAKDM4E | |
| SCHEMBL29224277 | 0.79 | KDM4E (0.47) | ALDH1A1POLBUSP2LMNAKDM4E | |
| SCHEMBL22323590 | 0.79 | MAPT (0.52) | ALDH1A1POLBUSP2LMNAKDM4E | |
| SCHEMBL22324061 | 0.79 | MAPT (0.52) | ALDH1A1POLBUSP2LMNAKDM4E | |
| SCHEMBL6028694 | 0.79 | MAPT (0.52) | ALDH1A1POLBUSP2LMNAKDM4E | |
| SCHEMBL10361297 | 0.79 | CYP2D6 (0.51) | ALDH1A1POLBUSP2LMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117658790-A | Novel preparation method of L-menthyl formic acid | 广州百花香料股份有限公司 | 2024-03-08 | — | — | CN | claimed |
| CN-117069585-A | Preparation method of ethyl 2-cyclohexanone formate | 烟台舜康生物科技有限公司 | 2023-11-17 | — | — | CN | claimed |
| CN-115583871-B | All C 13 Preparation method of isotope labeled decabromodiphenyl ether | 烟台大学 | 2023-05-12 | — | — | CN | claimed |
| CN-115286575-A | Quinolinone seven-eight membered ring derivative and synthesis method and application thereof | 河南科技大学 | 2022-11-04 | — | — | CN | claimed |
| CN-118558364-A | Polyfluoroalkyl modified COFs supported nano palladium catalyst and preparation method and application thereof | 中南大学 | 2024-08-30 | — | — | CN | disclosed |
| CN-118525005-A | Polycyclic derivative containing pyridine, preparation method and application thereof | 上海翰森生物医药科技有限公司 | 2024-08-20 | — | — | CN | disclosed |
| CN-115003671-B | JNK inhibitors, pharmaceutical compositions and uses thereof | 武汉朗来科技发展有限公司 | 2024-08-06 | — | — | CN | disclosed |
| CN-118290415-A | N-heteroaryl benzothiazole heterocyclic derivative, preparation method and application thereof | 西北农林科技大学 | 2024-07-05 | — | — | CN | disclosed |
| CN-117935945-A | Screening method of Cu-TEMPO catalytic system | 内蒙古工业大学 | 2024-04-26 | — | — | CN | disclosed |
| CN-117924327-A | Kras inhibitor compounds having macrocyclic structure | 上海湃隆生物科技有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-117658790-A | Novel preparation method of L-menthyl formic acid | 广州百花香料股份有限公司 | 2024-03-08 | — | — | CN | disclosed |
| US-11884837-B2 | Scratch and mar resistant automotive coatings | BASF COATINGS GMBH (DE) | 2024-01-30 | — | — | US | disclosed |
| WO-2004007709-A2 | PRODUCTION OF POLYKETIDES | BIOTICA TECHNOLOGY LIMITED (GB) | 2004-01-22 | — | — | WO | disclosed |
| US-20030130273-A1 | Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2003-07-10 | — | — | US | disclosed |
| WO-2002096426-A1 | HYDANTION DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-12-05 | — | — | WO | disclosed |
| CN-1070181-C | Organic peroxide stabilization with beta-dicarbonyl or cyclic alpha-diketone compounds | CK WITCO CORP (US) | 2001-08-29 | — | — | CN | disclosed |
| EP-0553801-B1 | Use of sulfur-containing acid phosphoric ester as internal release agent | MITSUI TOATSU CHEMICALS (JP) | 1997-04-23 | — | — | EP | disclosed |
| WO-1997006218-A1 | POWDER PAINT COMPOSITION | DSM N.V. (NL) | 1997-02-20 | — | — | WO | disclosed |
| US-5389708-A | Polymerizing polyisocyanate or polyisothiocyanate with polyol or polythiol in presence of thiophosphoric or dithiophosphoric acid ester | MITSUI TOATSU CHEMICALS, INC. (JP) | 1995-02-14 | — | — | US | disclosed |
| EP-0553801-A1 | Use of sulfur-containing acid phosphoric ester as internal release agent | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1993-08-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030130273-A1 | Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) | ADAM17, ADAMTS1, ADAM8 | ALDH1A1 701/4885POLB 2262/4885USP2 1187/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.